Please assess the completion status of the following clinical trial:

Trial Title: Open-Label Trial Comparing Oxycodone Medications

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Be at least 18 years old.~2. Be able to read and understand English.~3. Have a diagnosed chronic pain condition with pain every day or most days for the previous 6 months.~4. Be receiving the equivalent of no more than 40-120 mg daily of an opioid analgesic that can be safely converted to oxycodone; this dosage includes all use of opioid analgesics, including for rescue and for breakthrough pain.~5. Have an average daily pain rating for the baseline week of pain ratings equal to 4.0 or greater on a 0-10 numerical pain rating scale (NRS) of average pain intensity in the past 24 hours.~6. Have completed at least 6 of the 7 daily diaries during the baseline week.~7. Have at least 5 baseline week pain diary ratings equal to 3 or greater on the 0-10 NRS, with no more than one rating of 9 and no ratings of 10.~8. Have stable concomitant use of all pain-related medications for 8 weeks prior to screening and being willing to continue stable use of these medications for the duration of the trial.~9. Have the ability to either independently or with an accompanying person come to the research center for study visits.~Exclusion Criteria:~1. Treatment of their chronic pain with nerve blocks or any other interventional procedure within the past 8 weeks.~2. A Beck Depression Inventory score \< 27 at baseline or clinically significant depression or dementia that, in the opinion of the investigator, may interfere with a subjects' adherence to the study protocol and/or the accurate and consistent reporting of pain.~3. History of suicide attempt within the past 2 years or current suicide plan or intent.~4. History of excessive alcohol use or any illicit drug use within the past 2 years.~5. Lack of adequate birth control in pre-menopausal women of child-bearing age and/or a positive urine pregnancy test, which will be performed on all women except those \> 2 years post-menopausal or who have had a hysterectomy).~6. History of malignancy within the past five years with the exception of successfully treated non-metastatic basal cell or squamous cell carcinomas of the skin.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- ER Oxycodone vs IR Oxycodone (Type: ACTIVE_COMPARATOR): Extended release Oxycodone to assess pain relief adverse effects, treatment satisfaction and impact of treatment on health related quality of life.~IR oxycodone will be distributed to subjects in 5 mg pills and they will be instructed to take 3-4 of these pills every four hours

Based on this trial design, predict the completion outcome and termination type (if applicable).